Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib

Yuriko Yamamura; Yoshinori Matsumoto; Yosuke Asano; Yu Katayama; Keigo Hayashi; Keiji Ohashi; Michiko Morishita; Haruki Watanabe; Mariko Takano-Narazaki; Kenei Sada; Jun Wada

doi:10.1093/rap/rkz050

Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib

Yuriko Yamamura, Yoshinori Matsumoto, Yosuke Asano, Yu Katayama, Keigo Hayashi, Keiji Ohashi, Michiko Morishita, Haruki Watanabe, Mariko Takano-Narazaki, Kenei Sada, Jun Wada

Research output: Contribution to journal › Letter › peer-review

19 Citations (Scopus)

Original language	English
Article number	rkz050
Journal	Rheumatology Advances in Practice
Volume	4
Issue number	1
DOIs	https://doi.org/10.1093/rap/rkz050
Publication status	Published - Feb 6 2020

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1093/rap/rkz050

Cite this

@article{3314a4b99380405ea24d3a591a0283c9,

title = "Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib",

author = "Yuriko Yamamura and Yoshinori Matsumoto and Yosuke Asano and Yu Katayama and Keigo Hayashi and Keiji Ohashi and Michiko Morishita and Haruki Watanabe and Mariko Takano-Narazaki and Kenei Sada and Jun Wada",

note = "Funding Information: Funding: This work was not supported by any agency grants except for the cost of tofacitinib, which was supported by the Okayama University Hospital.",

year = "2020",

month = feb,

day = "6",

doi = "10.1093/rap/rkz050",

language = "English",

volume = "4",

journal = "Rheumatology Advances in Practice",

issn = "2514-1775",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib

AU - Yamamura, Yuriko

AU - Matsumoto, Yoshinori

AU - Asano, Yosuke

AU - Katayama, Yu

AU - Hayashi, Keigo

AU - Ohashi, Keiji

AU - Morishita, Michiko

AU - Watanabe, Haruki

AU - Takano-Narazaki, Mariko

AU - Sada, Kenei

AU - Wada, Jun

N1 - Funding Information: Funding: This work was not supported by any agency grants except for the cost of tofacitinib, which was supported by the Okayama University Hospital.

PY - 2020/2/6

Y1 - 2020/2/6

UR - http://www.scopus.com/inward/record.url?scp=85081660204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081660204&partnerID=8YFLogxK

U2 - 10.1093/rap/rkz050

DO - 10.1093/rap/rkz050

M3 - Letter

AN - SCOPUS:85081660204

SN - 2514-1775

VL - 4

JO - Rheumatology Advances in Practice

JF - Rheumatology Advances in Practice

IS - 1

M1 - rkz050

ER -

Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this